|
Zagaja, G P; Shrivastav, M; Fleig, M J et al. (1998) Effects of polyamine analogues on prostatic adenocarcinoma cells in vitro and in vivo. Cancer Chemother Pharmacol 41:505-12
|
|
Pegg, A E; Dolan, M E; Moschel, R C (1995) Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase. Prog Nucleic Acid Res Mol Biol 51:167-223
|
|
Dolan, M E; Chae, M Y; Pegg, A E et al. (1994) Metabolism of O6-benzylguanine, an inactivator of O6-alkylguanine-DNA alkyltransferase. Cancer Res 54:5123-30
|
|
Dolan, M E; Fleig, M J; Feuerstein, B G et al. (1994) Effect of 1,19-bis(ethylamino)-5,10,15-triazanonadecane on human tumor xenografts. Cancer Res 54:4698-702
|
|
Chae, M Y; McDougall, M G; Dolan, M E et al. (1994) Substituted O6-benzylguanine derivatives and their inactivation of human O6-alkylguanine-DNA alkyltransferase. J Med Chem 37:342-7
|
|
Kokkinakis, D M; Moschel, R C; Pegg, A E et al. (1994) Metabolism and disposition of O6-benzyl-2'-deoxyguanosine in Sprague-Dawley rats. Chem Res Toxicol 7:762-9
|
|
Dolan, M E; Pegg, A E; Moschel, R C et al. (1994) Biodistribution of O6-benzylguanine and its effectiveness against human brain tumor xenografts when given in polyethylene glycol or cremophor-EL. Cancer Chemother Pharmacol 35:121-6
|
|
Mitchell, R B; Dolan, M E; Janisch, L et al. (1994) Sequential therapy with dacarbazine and carmustine: a phase I study. Cancer Chemother Pharmacol 34:509-14
|
|
Marathi, U K; Dolan, M E; Erickson, L C (1994) Anti-neoplastic activity of sequenced administration of O6-benzylguanine, streptozotocin, and 1,3-bis(2-chloroethyl)-1-nitrosourea in vitro and in vivo. Biochem Pharmacol 48:2127-34
|
|
Bishop, R E; Dunn, L L; Pauly, G T et al. (1993) The role of O6-alkylguanine-DNA alkyltransferase in protecting Rat4 cells against the mutagenic effects of O6-substituted guanine residues incorporated in codon 12 of the H-ras gene. Carcinogenesis 14:593-8
|
Showing the most recent 10 out of 25 publications
